We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Disease Modelling and Drug Discovery in Neurological Disorders

Video   Apr 29, 2016

 


About the Speaker
Zameel Cader Is Scientific Director of IMI StemBANCC and is the Director of the Oxford Headache Centre. He is also Clinical Director for Mental Health, Dementia and Neurology for the Strategic Clinical Network. He is Associate Professor in Clinical Neurosciences at the Nuffield Department of Clinical Neuroscience and the Weatherall Institute of Molecular Medicine. His research programme is focused on understanding the disease process in neurodysfunctional disorders such as migraine and neurodegenerative disorders such as Alzheimer's Disease using cell biology, model organism and human imaging studies. His group is now working with MRC Technology to bring more effective treatments arising from these findings to clinic.
AbstractThis presentation will focus on stemBANCC and its progress in developing disease relevant models as well as how we hope to turn these into drug screening assays.

 
 
 
 

Recommended Videos

Ulcerative Colitis: Fresh Approaches to Taming Inflammation

Video

This animation explores how insights into the immunobiology of ulcerative colitis are helping researchers to develop innovative treatments.

WATCH NOW

The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process

Video

Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.

WATCH NOW

Researchers love this microplate spectrophotometer - Thermo Scientific Multiskan Sky

Video

Plate reader with ready-made protocols, cloud connected, touch screen, no learning curve. Researchers from the University of Helsinki Pharmacy dept. review the Thermo Scientific Multiskan Sky Microplate Spectrophotometer as efficient and easy-to-use.

WATCH NOW

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE